1. Novel activators and small-molecule inhibitors of STAT3 in cancer
   Lehe Yang et al, 2019, Cytokine & Growth Factor Reviews CrossRef
2. Mechanisms of Cytotoxicity of Chemical Agents to Giant Cell Tumors: An In Vitro Study
   Achmad Fauzi Kamal et al, 2020, Stem Cells International CrossRef
3. Bortezomib Rescues Ovariectomy-Induced Bone Loss via SMURF-Mediated Ubiquitination Pathway
   Yuepeng Fang et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
4. Tubacin Histone Deacetylase 6 Inhibitor Produced α-Tubulin Acetylation, Cell Cycle Arrest, Aging, and Suppression of Migration of Mouse Fibroblasts Transformed by E1A and cHa-ras Oncogenes
   A. N. Kukushkin et al, 2023, Cell and Tissue Biology CrossRef
5. G3BP1 knockdown sensitizes U87 glioblastoma cell line to Bortezomib by inhibiting stress granules assembly and potentializing apoptosis
   L. F. F. Bittencourt et al, 2019, Journal of Neuro-Oncology CrossRef
6. Downregulation of SKP2 in Papillary Thyroid Cancer Acts Synergistically With TRAIL on Inducing Apoptosis via ROS
   Poyil Pratheeshkumar et al, 2018, The Journal of Clinical Endocrinology & Metabolism CrossRef
7. Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells
   Dylan Jones et al, 2023, Molecular and Cellular Biochemistry CrossRef
8. Oncogenetic landscape of lymphomagenesis in coeliac disease
   Sascha Cording et al, 2022, Gut CrossRef
9. Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells
   Shifaa M. Abdin et al, 2021, Chemico-Biological Interactions CrossRef
10. The Efficacy and Mechanism of Proteasome Inhibitors in Solid Tumor Treatment
    Di Zhang et al, 2022, Recent Patents on Anti-Cancer Drug Discovery CrossRef
11. Refractory celiac disease and lymphomagenesis
    Marco Vincenzo Lenti et al, 2024, Pediatric and Adult Celiac Disease CrossRef
12. Update on the Pathogenesis of Enteropathy-Associated T-Cell Lymphoma
    Shahed Azzam Ahmed Abdullah et al, 2023, Diagnostics CrossRef
13. Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signaling
    Zhipeng Su et al, 2021, Cell Death & Disease CrossRef
14. Crosstalk and Interplay between the Ubiquitin-Proteasome System and Autophagy
    Chang Hoon Ji et al, 2017, Molecules and Cells CrossRef
15. STAT3 promotes RNA polymerase III-directed transcription by controlling the miR-106a-5p/TP73 axis
    Cheng Zhang et al, 2023, eLife CrossRef
16. GRP78 modulates cell adhesion markers in prostate Cancer and multiple myeloma cell lines
    Christopher N. Cultrara et al, 2018, BMC Cancer CrossRef
17. Study effect of traditional chemotherapy compared with the effect of combination (chemotherapeutic plus paroxetine) on cell line of multiple myeloma
    Zahraa A. H. Al-Tameemi et al, 2023, THE SECOND INTERNATIONAL SCIENTIFIC CONFERENCE (SISC2021): College of Science, Al-Nahrain University CrossRef
18. The E2 ubiquitin-conjugating enzyme CfRad6 regulates the autophagy and pathogenicity of Colletotrichum fructicola on Camellia oleifera
    Jing Luo et al, 2023, Phytopathology Research CrossRef
19. A protein–protein interaction map reveals that the Coxiella burnetii effector CirB inhibits host proteasome activity
    Mengjiao Fu et al, 2022, PLOS Pathogens CrossRef